Finfeed Archived Apr 01, 2021
Creso Pharma (ASX: CPH) has launched its CBD-based teas in Switzerland with other European markets preparing for expansion.
Get expert stock analysis direct in your inbox
Join OurMailing List
Discover Small CapBiotech Stocks
Join thousands of other Investors following our stock commentary for Free